Evidence map›Paper›PMID 36297428›Full record

ArticlePharmaceutics2022

Bactericidal Activity of Carvacrol against

Niluni M Wijesundara, Song F Lee, Zhenyu Cheng, Ross Davidson, David N Langelaan, H P Vasantha Rupasinghe

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Montelukast treatsMicrobiology spectrum · 2025
    Article
  5. Article
  6. Review
  7. Microorganisms · 2025
    Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Niluni M WijesundaraDepartment of Biology, Faculty of Science, Dalhousie University, Halifax, NS B3H 3E2, Canada.
Song F LeeDepartment of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 3E2, Canada.
Zhenyu ChengDepartment of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 3E2, Canada.ORCID 0000-0002-7240-9126
Ross DavidsonDepartment of Microbiology & Immunology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 3E2, Canada.
David N LangelaanDepartment of Biochemistry & Molecular Biology, Faculty of Medicine, Dalhousie University, Halifax, NS B3H 3E2, Canada.ORCID 0000-0001-9592-3075
H P Vasantha RupasingheDepartment of Biology, Faculty of Science, Dalhousie University, Halifax, NS B3H 3E2, Canada.ORCID 0000-0003-3435-0052
Dalhousie University · CA

Funding

Natural Sciences and Engineering Research Council CRDPJ 448052
6 · The paper itself

Abstract

backgroundCarvacrol, a mono-terpenoid phenol found in herbs, such as oregano and thyme, has excellent antibacterial properties against

objectivesThis study investigated the bactericidal mechanism of carvacrol using three strains of

methodsFlow cytometry (FCM) experiments were conducted to determine carvacrol's membrane permeabilization and cytoplasmic membrane depolarization activities. Protoplasts of

resultsIncreased membrane permeability and decreased membrane potential from FCM and electron microscopy observations revealed that carvacrol killed the bacteria primarily by disrupting membrane integrity, leading to whole-cell lysis. Ultra-structural morphological changes in the membrane induced by carvacrol over a short period were confirmed using the

conclusionsCarvacrol exhibited rapid bactericidal action against

Indexed as

carvacrolmechanism of actionmembranepermeabilityphospholipidsstreptococcal pharyngitisStreptococcus pyogenes

Identifiers

PMID36297428
PMCPMC9607399
OpenAlexW4296613884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.